Product and Service to Lead Genotyping Market During 2022–2028
According to our latest study on “Genotyping Market Forecast to 2028 – COVID-19 Impact and Global Analysis – By Product and Service, Technology, Application, End-User, and Geography," the market is expected to reach US$ 79,407.14 million in 2028 from US$ 25,191.28 million in 2022; it is estimated to grow at a CAGR of 20.1% during 2022–2028. The report highlights the key factors driving the Genotyping market growth and prominent players with their developments in the Genotyping market. Key factors driving the market's growth are the use of genotyping in drug development for genetic and rare diseases, technological advancements, and rising R&D investments in pharmaceutical and biotechnology. However, the high equipment cost and the shortage of skilled professionals are expected to restrict the market growth during the forecast period.
The COVID-19 pandemic diverted resources from healthcare services for patients with diseases. The Genotyping market witnessed some shortfall at the beginning of the COVID-19 crisis owing to factors such as disruption in the supply chain and demand due to the lack of lockdown announced by most countries. The COVID-19 pandemic altered economic conditions and social behaviors across the globe. However, the COVID-19 pandemic led to the increased demand for genetic testing of the samples to identify the variants of SARS-CoV-2 as the virus was being mutated significantly in various geographic locations worldwide. The genotyping market witnessed positive growth with the high technological and advanced research initiatives and increased demand for COVID-19 genotyping kits during the pandemic. For instance, in June 2020, Illumina received the FDA Emergency Use Authorization for “COVIDSeq,” a Sequencing-Based COVID-19 Diagnostic Test. This test includes 98 amplicons to target the entire SARS-CoV-2 genome, creating efficient detection and high sensitivity.
The genotyping market is segmented based on product and services: reagents and kits, bioinformatics, genotyping services, and instruments. In 2022, the reagents and kits will likely account for the market's largest share. Moreover, the same segment is anticipated to register the highest CAGR in the market from 2022 to 2028. The increased demand by the consumers is one of the significant trends in the global Genotyping market. These products make it easy to observe genetic variation in people, animals, organisms, and individual genes. A wide range of genotyping kits is available from several major companies. For instance, Sanger sequencing kits and reagents are used for PCR amplification of region(s) of interest, cycle sequencing, and reaction cleanup. Target selection, library construction, and template preparation can be completed with these kits and reagents. Furthermore, Amplification fragment length polymorphism (AFLP), SNP genotyping, high-resolution melt analysis (HRM), animal DNA extraction, and qPCR genotyping are among the other kits available on the market.
F. Hoffmann-La Roche Ltd., Integrated DNA Technologies, Inc. (Danaher), Qiagen, Merck KGaA, Eurofins Genomics, Thermo Fisher Scientific Inc., BioTek Instruments, Inc., Xcelris Genomics, Trimgen Corporation, and Illumina, Inc. are a few leading companies operating in the global Genotyping market. For instance, in November 2021, F. Hoffmann – La Roche Ltd. Launched the Cobas 5800 System, which is a compact new addition to the Roche Molecular portfolio, providing efficiency, simplicity, and timely results to laboratories of all sizes so clinicians can quickly determine the best treatment strategies for their patients.
Genotyping Market, by Geography, 2022 (%)
Genotyping Market Size, Share, Growth, Forecast by 2028
Download Free Sample
Genotyping Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Service (Instruments, Reagents and Kits, Bioinformatics, and Genotyping Services), Technology (Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction (PCR), Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry, and Others), Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others), End-User (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Other), and Geography
Genotyping Market Size, Share, Growth, Forecast by 2028
Download Free SampleGenotyping Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Service (Instruments, Reagents and Kits, Bioinformatics, and Genotyping Services), Technology (Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction (PCR), Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry, and Others), Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others), End-User (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Other), and Geography
The report segments the Genotyping market as follows:
Based on product and services, the market is segmented into reagents and kits, bioinformatics, genotyping services, and instruments. Based on Technology, the market is segmented into Microarrays, Capillary Electrophoresis, Sequencing, Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-ToF) Mass Spectrometry, Polymerase Chain Reaction (PCR), and Others. Based on Application, the market is segmented into Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others. Based on End-User, the global Genotyping market is segmented into Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Others. Based on geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com